Dermatology Drugs Market [(By Therapeutic Area (Atopic Dermatitis, Psoriasis, Acne, Rosacea), By Marketed Therapies (Biologics, Oral Drugs, Topical Drugs), By Approved Treatments (etanercept (Enbrel), infliximab (Remicade), adalimumab (Humira), ustekinumab (Stelara), secukinumab (Cosentyx), ixekizumab (Taltz), golimumab (Simponi), brodalumab (Siliq), and guselkamab (Tremfya), and By Region]: Market Size & Forecast, 2017 – 2022

By using this form you agree with the storage and handling of your data by this website.

Single User - $ 3,980 Multi Users(Up to 20 User)- $ 4,980 Enterprise License - $ 6,250 Buy Now

全球皮肤病药物市场规模和股份 - 行业报告，2022年